Johnson & Johnson

JNJ-N

NYSE:JNJ

149.17
0.97 (0.65%)
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
More at Wikipedia

Analysis and Opinions about JNJ-N

Signal
Opinion
Expert
BUY
BUY
August 27, 2003
Trading at a discounted valuation. They are getting competition with their stents. At a decent valuation. Should see some upside from here.
Show full opinionHide full opinion
Trading at a discounted valuation. They are getting competition with their stents. At a decent valuation. Should see some upside from here.
BUY
BUY
August 22, 2003
Pharmaceutical stocks are defensive in nature.In this environment, nobody's buying them.Will be dead money in the short term.A good price to buy out for the long-term.
Show full opinionHide full opinion
Pharmaceutical stocks are defensive in nature.In this environment, nobody's buying them.Will be dead money in the short term.A good price to buy out for the long-term.
BUY
BUY
August 20, 2003
They have a huge consumer business.The drug sector has been sluggish.Longer term this should pick up.
Show full opinionHide full opinion
They have a huge consumer business.The drug sector has been sluggish.Longer term this should pick up.
WEAK BUY
WEAK BUY
June 30, 2003
Book value is about $8 a share. Drug companies always seem to do well.
Show full opinionHide full opinion
Book value is about $8 a share. Drug companies always seem to do well.
BUY
BUY
May 16, 2003
Stable growth. Valuation may be a little high, but OK.
Show full opinionHide full opinion
Stable growth. Valuation may be a little high, but OK.
DON'T BUY
DON'T BUY
January 13, 2003
A defensive stock, so could lag a bit.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
January 13, 2003
A defensive stock, so could lag a bit.
BUY
BUY
December 6, 2002
Great company. Into stents now which will be a big market opportunity.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 6, 2002
Great company. Into stents now which will be a big market opportunity.
BUY
BUY
October 23, 2002
Well rounded in different health areas.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
October 23, 2002
Well rounded in different health areas.
Johnson & Johnson (JNJ-N)
October 15, 2002
PAST TOP PICK
PAST TOP PICK
September 20, 2002
(Was a top pick on July 17. No change.) Still likes. A core holding.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
September 20, 2002
(Was a top pick on July 17. No change.) Still likes. A core holding.
DON'T BUY
DON'T BUY
August 16, 2002
Expensive now. Good long term hold.
Show full opinionHide full opinion
Expensive now. Good long term hold.
TOP PICK
TOP PICK
July 17, 2002
Great price. Should appreciate 15% a year. Good numbers.
Show full opinionHide full opinion
Great price. Should appreciate 15% a year. Good numbers.
BUY
BUY
July 10, 2002
A good long term hold. Good price.
Show full opinionHide full opinion
A good long term hold. Good price.
WAIT
WAIT
June 28, 2002
Benefiting from weaker US $. Wait for it to reverse its down trend.
Show full opinionHide full opinion
Benefiting from weaker US $. Wait for it to reverse its down trend.
BUY
BUY
May 30, 2002
Bullish. International.No generic drug problems. Good cash flow from a lot of coonsumer products.
Show full opinionHide full opinion
Bullish. International.No generic drug problems. Good cash flow from a lot of coonsumer products.
Showing 406 to 420 of 438 entries